Virtus Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

Virtus Investment Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Buy	3,133 +402	+15%	+$225K	0.38%	99
2026 Q1	$1.53M	Sell	2,731 -276	-9%	-$177K	0.42%	114
2025 Q4	$2.03M	Sell	3,007 -224	-7%	-$153K	0.55%	40
2025 Q3	$2.06M	Buy	+3,231	New	+$1.96M	0.59%	19
2018 Q1	–	Sell	-1,706	Closed	-$267K	–	217
2017 Q4	$267K	Sell	1,706 -182	-10%	-$28.6K	0.03%	365
2017 Q3	$293K	Sell	1,888 -179	-9%	-$28.3K	0.03%	367
2017 Q2	$334K	Sell	2,067 -366	-15%	-$59.4K	0.03%	367
2017 Q1	$376K	Buy	+2,433	New	+$335K	0.03%	348

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Virtus Investment Advisers's IDXX Position: Q2 2026 in Review

Virtus Investment Advisers increased its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, buying an estimated $225K and bringing the position to 3,133 shares worth $1.65M. The position accounts for 0.38% of the portfolio, ranked #99.

Virtus Investment Advisers first reported a position in IDXX in Q1 2017 and has held it in 8 quarters since. The position peaked at $2.06M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Virtus Investment Advisers held 3,133 shares of Idexx Laboratories worth $1.65M as of Q2 2026.
Virtus Investment Advisers bought 402 Idexx Laboratories shares in Q2 2026, an estimated $225K.
Idexx Laboratories made up 0.38% of Virtus Investment Advisers's portfolio in Q2 2026, its #99 holding.
Virtus Investment Advisers first reported a position in Idexx Laboratories in Q1 2017 and has held it in 8 quarters since.
Virtus Investment Advisers's Idexx Laboratories position peaked at $2.06M in Q3 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.